263
The federal investigation into Blue Cross and Blue Shield of North Carolina, the state's largest health insurer, has officially come to an end. The U.S. Department of Health and Human Services concluded its examination of a complaint filed against the insurer over a year ago.
The investigation stemmed from allegations made by several advocacy groups, accusing Blue Cross of discriminatory pricing practices related to medications for patients with HIV. The complaint prompted a thorough review by the U.S. Department of Health and Human Services into the insurer's pharmaceutical pricing policies.